Monday, May 23, 2016

Insys Accused of Medical Fraud in Promotion of Fentanyl Pain Spray

Originally published by Robert Kraft.


NBC News reports on its website that drugmaker Insys Therapeutics “is pushing pain to the legal edge of aggressive medical marketing.” According to “criminal complaints, attorneys general reports and CNBC sources,” NBC News reports that Insys has been accused of marketing its “highly addictive” oral pain spray, Subsys (fentanyl sublingual spray), by “pushing the drug far beyond” its indication for cancer patients and “engaging in potentially fraudulent activities in the process.” According to “several sources – and emails obtained from current and former employees of Insys, as well as from physicians,” Insys sales staff members “were under immense pressure, including threats of termination, to get doctors to write more prescriptions and higher doses of Subsys for everything from neck pain to migraines.”

From the news release of the American Association for Justice.

Curated by Texas Bar Today. Follow us on Twitter @texasbartoday.

from Texas Bar Today
via Abogado Aly Website

No comments:

Post a Comment